A. Anzueto (San Antonio, United States of America), O. Rajas (Madrid, Spain)
Clinical feature of Japanese patients with healthcare-associated pneumonia
K. Umeki, I. Tokimatsu, A. Iwata, H. Sonoda, S. Ohtani, C. Yasuda, D. Yoshioka, K. Hashinaga, H. Ishii, R. Shirai, K. Kishi, K. Hiramatsu, T. Matsumoto, J. I. Kadota (Yufu, Oita, Japan)
|  |
Health care associated pneumonia requiring hospitalisation
R. Uzun, B. O. Baysan, A. Cilli (Antalya, Turkey)
| |
Prevalence of aspirations in older patients with pneumonia is high and related to delayed swallow response
J. Almirall, R. Icart, M. Cabré, V. Arreola, A. Martin, T. Fernandez, R. Bisbal, M. Serra, J. C. Yébenes, P. Clavé (Mataró, Spain)
|  |
Procalcitonin(PCT) levels correlate with severity of illness in health care-associated pneumonia(HCAP)
A. Ito, T. Ishida, H. Tachibana, S. Ubukata, H. Fukuyama, C. Iga (Kurashiki-City, Japan)
| |
Invasive vs non-invasive techniques for diagnosing ventilatory acquired pneumonia
H. Hanan, N. Youssef, M. Mikdad, A. Khoury (Aleppo, Syrian Arab Republic)
| |
Community acquired pneumonia (CAP): Audit of current practice in an English district general hospital
G. Trafford, J. Prabha, J. Mukherjee (Warwick, United Kingdom)
| |
The comparison of hospitalized healthcare-associated pneumonia with community-acquired pneumonia patients
M. S. Tasbakan, B. Basarik, S. Citim Tuncel, A. Gurgun, O. K. Basoglu, F. Bacakoglu (Izmir, Turkey)
| |
Are there radiographic differences between patients with community-acquired (CAP) and healthcare-associated pneumonias (HCAP)?
V. Brito, T. Youn, N. Brar, M. Feuerman, D. Katz, M. Niederman (Mineola, United States Of America)
| |
Clinical outcomes of patients with HAP/VAP due to PVL(+) vs. PVL(-) MRSA: Results from the IMPACT-HAP study
P. Peyrani, T. Wiemken, M. Zervos, T. File, Jr., K. Ford, E. Scerpella, J. Ramirez, IMPACT-HAP Investigators (Louisville, Detroit, Aakron, New York, United States Of America)
| |
Related factors to PSI IV-V community acquired pneumonia admitted to ICU
C. Senent, E. Chiner, J. N. Sancho-Chust, E. Fernández-Fabrellas, A. Cervera, F. Sanz, M. D. C. Aguar, J. Blanquer (Valencia, Spain)
| |
Validation of pneumonia severity models for healthcare-associated pneumonia (HCAP)
S. Brown, J. Jones, B. Jones, M. Lanspa, A. Jephson, Y. Li, N. Dean (Murray, Salt Lake City, United States Of America)
| |
Comparative study of clinical diagnostic criteria for ventilator-associated pneumonia
M. Pereira Cervan, C. Stipanich, T. Silva Souza, S. Zahi Rached, L. M. Brasileiro Gomes, I. C. Vilela Soares Oshiro, C. Tanaka, C. Fu, C. R. Ribeiro de Carvalho (Sao Paulo, Brazil)
| |
I-ROAD could be efficient in predicting severity of community acquired pneumonia (CAP) or healthcare-associated-pneumonia(HCAP)
R. Matsunuma, Y. Ohkuni, K. Nakashima, K. Ando, T. Iwasaki, N. Asai, D. Yasui, M. Misawa, N. Kaneko (Kamogawa City, Japan)
| |
Health care associated pneumonia (HCAP) and community acquired pneumonia (CAP): Are they different diseases?
M. Carrabba, M. Zarantonello, F. Minonzio, P. Bonara, G. Fabio (Italy)
| |
Risk factors analysis influenced occurrence of ventilator-associated pneumonia in surgical intensive care unit
H. Shoji, T. Takuma, K. Yoshida, Y. Niki (Tokyo, Japan)
| |
Factors on admission influencing site-of-care decision for patients hospitalised for community acquired pneumonia
S. Kihrani, F. Piffer, M. Di Pasquale, G. Salomoni, L. Morlacchi, C. Travierso, R. Cosentini, P. Tarsia (Milan, Italy)
| |
Failure to reach clinical stability in community acquired pneumonia
A. Akram, J. Chalmers, A. Singanayagam, P. Mandal, G. Choudhury, A. Hill (United Kingdom)
| |
Relationship between selected initial treatment of healthcare associated pneumonia with changing treatment,intensive care requirement, hospitalization period and death rate
M. Kaya, O. Kilinc, T. Gunay (Izmir, Turkey)
| |
Seasonal variation in outcome for hospitalised patients with community-acquired pneumonia
R. Callus, J. Micallef, J. Mamo, S. Montefort (Birkirkara, Malta; Nottingham, United Kingdom)
| |
Short-term risk of acute myocardial infarction among patients with community-acquired pneumonia
A. Vila-Corcoles, E. Salsench-Serrano, O. Ochoa-Gondar, I. Hospital-Guardiola, M. Jariod-Pamias, EPIVAC Study Group (Tarragona, Spain)
| |